Toggle navigation
Home
Search
Services
Blog
Contact
About
Production of A Recombinant H5 N1 Vaccine for Phase 1
Smith, Gail
Protein Sciences Corporation, Meriden, CT, United States
Search 21 grants from Gail Smith
Search grants from Protein Sciences Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Alternatives and Illinois Department of Children and Family Services'A-CRA/ACC P
Integrative Cell Biophysics
Replication of the SV40 Genome
Interaction of RNA Polymerase and DNA;Sequence Effects
Righting Unrightable Wrongs: Legacies of Racial Violence in the U.S. South
Recently added grants:
New ACE2 activator and its prodrug as novel therapeutic reagents for inflammatory pulmonary diseases
Animal Core
Pilot Project Core
Research Project 1: The CASP4/11-GSDMD Pathway in Alcoholic Hepatitis
Non-coding RNA functions in tumor metastasis
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research and Development Contracts (N01)
Project #
N01AI085333-002
Application #
2830748
Study Section
Project Start
1997-12-19
Project End
1998-12-18
Budget Start
1998-06-16
Budget End
1998-04-18
Support Year
Fiscal Year
1998
Total Cost
Indirect Cost
Institution
Name
Protein Sciences Corporation
Department
Type
DUNS #
City
Meriden
State
CT
Country
United States
Zip Code
06450
Related projects
NIH 1998
N01 AI
Production of A Recombinant H5 N1 Vaccine for Phase 1
Smith, Gail / Protein Sciences Corporation
NIH 1998
N01 AI
Production of A Recombinant H5 N1 Vaccine for Phase 1
Smith, Gail / Protein Sciences Corporation
Comments
Be the first to comment on this grant